Age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
Ethnicity All
Item
all genders and ethnicity
boolean
C0015031 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
Hepatitis B surface antigen positive
Item
positive hbsag
boolean
C0149709 (UMLS CUI [1])
Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
hbeag positive and negative
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
Pretreatment Hepatitis B DNA Measurement
Item
pretreatment hbv dna of 10,000 copies/ml or higher (for purposes of this study, both copies and equivalent iu measurements will be recorded and analyzed)
boolean
C3539075 (UMLS CUI [1,1])
C3641250 (UMLS CUI [1,2])
Adefovir | Change of medication | Entecavir | Entecavir prescribed
Item
patients who are switched to, or prescribed, entecavir after treatment with adefovir for at least 12 weeks by the providing physician.
boolean
C0050175 (UMLS CUI [1])
C0580105 (UMLS CUI [2])
C0971023 (UMLS CUI [3])
C0971023 (UMLS CUI [4,1])
C0278329 (UMLS CUI [4,2])
Exposure to Lamivudine | Absence Exposure to Lamivudine
Item
patients with and without prior lamivudine exposure will be enrolled but enrollment of lamivudine experienced cases will be limited to no more than 30 patients total
boolean
C0332157 (UMLS CUI [1,1])
C0209738 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0209738 (UMLS CUI [2,3])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Informed Consent Refused
Item
patients who refused to consent to the study
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Age
Item
patients younger than 18
boolean
C0001779 (UMLS CUI [1])
Vulnerable adult | Pregnant Women | Prisoners | Employee | Patients Impaired cognition
Item
vulnerable subjects such as pregnant women, prisoners, employees, patients with significant cognitive deficits.
boolean
C1562367 (UMLS CUI [1])
C0033011 (UMLS CUI [2])
C0033167 (UMLS CUI [3])
C0599987 (UMLS CUI [4])
C0030705 (UMLS CUI [5,1])
C0338656 (UMLS CUI [5,2])
Exposure to Nucleosides | Exception Exposure to Lamivudine
Item
patients with prior exposure to another nucleoside for more than 2 weeks. those with prior exposure to lamivudine will be enrolled under conditions detailed above.
boolean
C0332157 (UMLS CUI [1,1])
C0028621 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0209738 (UMLS CUI [2,3])
HIV coinfection
Item
hiv co-infection
boolean
C4062778 (UMLS CUI [1])
HCV coinfection
Item
hcv co-infection
boolean
C1698259 (UMLS CUI [1])
HDV Coinfection
Item
hdv co-infection
boolean
C0011220 (UMLS CUI [1,1])
C0275524 (UMLS CUI [1,2])
Solid organ transplant Recipient
Item
recipients of solid organ transplantation
boolean
C0730400 (UMLS CUI [1,1])
C1709854 (UMLS CUI [1,2])
Steroids High dose
Item
patients who receive high-dose steroid (60 mg/d or higher and for longer than 10 days)
boolean
C0038317 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])